Deal also involves a stake sale by Apollo besides fresh issue.
The PE firm had invested through a preferential allotment in December 2013.
Koye is into essential drugs for primary specialty care.
The firm is backed by ChrysCap.
Ranbaxy is awaiting regulatory approvals to be acquired by Sun Pharma.
E-com firms are not valued on the basis of their 'net revenues' Suresh. It's more a function of actual value of...
"This values the company at around $350 million, less than what it could have been valued at given its net revenues...
Sigh! 32 Million of tax payer's money...
no doubt now that india is going to fail in entrepreneurship also